Early abnormalities of pulmonary vascular development in the Fawn-Hooded rat raised at Denver's altitude

被引:39
作者
Le Cras, TD
Kim, DH
Markham, NE
Abman, SH
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Pediat,Pediat Heart Lung Ctr, Denver, CO 80262 USA
[2] Childrens Hosp, Denver, CO 80262 USA
[3] Hallym Univ, Dept Pediat, Seoul 150030, South Korea
关键词
alveolarization; lung development; lung hypoplasia; endothelial nitric oxide synthase;
D O I
10.1152/ajplung.2000.279.2.L283
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The Fawn-Hooded rat (FHR) is a genetic strain that has been extensively studied as a model of primary pulmonary hypertension in adult rats. Based on our recent observations that alveolar number and pulmonary arterial density are reduced in FHRs raised at Denver's altitude, we hypothesized that early abnormalities in pulmonary vascular development contribute to the progression of pulmonary hypertension in the FHR. We found that endothelial nitric oxide synthase (eNOS) protein content was lower in the lungs of fetal, 1- and 7-day-old, 3-week-old, and adult FHRs compared with that in the normal Sprague-Dawley (SDR) and Fischer rat strains, all raised at Denver's altitude. In contrast, lung expression of the endothelial proteins kinase insert domain-containing receptor/fetal liver kinase-1 (KDR/Flk-1) and platelet endothelial cell adhesion molecule-1 (CD31) was not different between strains. Barium arteriograms showed that pulmonary arterial density was reduced in 3-week-old FHRs compared with SDRs. Perinatal treatment of FHRs with mild hyperbaria to simulate sealevel alveolar PO2 improved lung eNOS content and pulmonary vascular growth and reduced right ventricular hypertrophy. We conclude that the development of pulmonary hypertension in Denver-raised FHRs is characterized by reductions in lung eNOS expression and abnormal pulmonary vascular growth during the fetal, neonatal, and postnatal periods.
引用
收藏
页码:L283 / L291
页数:9
相关论文
共 36 条
[31]   INCREASED LUNG ENDOTHELIN-1 PRODUCTION IN RATS WITH IDIOPATHIC PULMONARY-HYPERTENSION [J].
STELZNER, TJ ;
OBRIEN, RF ;
YANAGISAWA, M ;
SAKURAI, T ;
SATO, K ;
WEBB, S ;
ZAMORA, M ;
MCMURTRY, IF ;
FISHER, JH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (05) :L614-L620
[32]   Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene [J].
Steudel, W ;
Ichinose, F ;
Huang, PL ;
Hurford, WE ;
Jones, RC ;
Bevan, JA ;
Fishman, MC ;
Zapol, WM .
CIRCULATION RESEARCH, 1997, 81 (01) :34-41
[33]   THE EFFECT OF NITRIC-OXIDE ON FETAL PULMONARY-ARTERY SMOOTH-MUSCLE GROWTH [J].
THOMAE, KR ;
NAKAYAMA, DK ;
BILLIAR, TR ;
SIMMONS, RL ;
PITT, BR ;
DAVIES, P .
JOURNAL OF SURGICAL RESEARCH, 1995, 59 (03) :337-343
[34]   Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension [J].
Tyler, RC ;
Muramatsu, M ;
Abman, SH ;
Stelzner, TJ ;
Rodman, DM ;
Bloch, KD ;
McMurtry, IF .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 276 (02) :L297-L303
[35]   Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus [J].
Villamor, E ;
LeCras, TD ;
Horan, MP ;
Halbower, AC ;
Tuder, RM ;
Abman, SH .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 272 (05) :L1013-L1020
[36]   NITRIC-OXIDE MEDIATES ANGIOGENESIS IN-VIVO AND ENDOTHELIAL-CELL GROWTH AND MIGRATION IN-VITRO PROMOTED BY SUBSTANCE-P [J].
ZICHE, M ;
MORBIDELLI, L ;
MASINI, E ;
AMERINI, S ;
GRANGER, HJ ;
MAGGI, CA ;
GEPPETTI, P ;
LEDDA, F .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :2036-2044